Instrument/Protocol

This resource offers background information and tips for providers on how to use person-first language and on which terms to avoid using to reduce stigma and negative bias when discussing addiction or substance use disorder with pregnant women and mothers.

The primary objectives of the SOURCE (Simulation of Opioid Use, Response, Consequences, and Effects) model are threefold: help the FDA and other stakeholders identify high-impact opioid-related interventions, assess potential unanticipated consequences of potential policies, and identify needs for further research.

This Treatment Improvement Protocol (TIP) was written to help counselors and organizations provide culturally responsive services.

A list of FAQs which pertain to Syringe Services Programs (SSPs), community-based programs that provide access to sterile needles and syringes, facilitate safe disposal of used syringes, and provide and link to other important services and programs.

Tips to help people stay safer and healthier no matter how they choose to change your use.

A final recommendation statement from the U.S. Preventive Services Task Force (USPSTF) on screening for unhealthy drug use.

The BMC MAT Quick Start App utilizes interactive clinical algorithms to walk clinicians through each step of the medication initiation process and pain management recommendations for patients with OUD. The app does not replace clinical decision-making and is meant to help inform clinicians regarding the use of medications for opioid use disorder.

This Telehealth Capacity Assessment Tool (TCAT) helps behavioral health organizations: 1) measure their capacity in accordance with these factors; 2) identify capacity building needs and plan for development in strategic areas; and 3) monitor and evaluate the impact of their capacity building efforts.

These clinical tools include guidance and forms for the implementation of medication-assisted treatment in ambulatory care settings.

The PRO screens pregnant women for psychosocial risk factors that may affect a healthy pregnancy or birth or impede a woman’s ability to comply with prenatal care recommendations.